Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2022 16:57 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million

LEXINGTON, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
March 29, 2022 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Host Analyst and Investor Day on April 12, 2022

LEXINGTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
February 17, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results

LEXINGTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
February 16, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Commercial Expansion Through Distributors in Norway, Finland and Türkiye

LEXINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of territory...
February 15, 2022 09:27 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement

LEXINGTON, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the successful amendment and...
February 08, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report Fourth Quarter and Full Year 2021 Financial Results on February 17, 2022

LEXINGTON, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial...
February 04, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., Feb. 04, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to...
February 03, 2022 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Subvariants

LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel...
January 11, 2022 09:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial...
January 11, 2022 09:03 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces the Initiation of the T2Biothreat® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical...